SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-072999
Filing Date
2020-06-12
Accepted
2020-06-12 17:18:49
Documents
3
Effectiveness Date
2020-06-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2022268d2_defa14a.htm DEFA14A 20928
2 GRAPHIC tm2022268d2_defa14aimg001.jpg GRAPHIC 358024
3 GRAPHIC tm2022268d2_defa14aimg002.jpg GRAPHIC 208224
  Complete submission text file 0001104659-20-072999.txt   802308
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36020 | Film No.: 20961127
SIC: 2834 Pharmaceutical Preparations